dividend

Buy & Hold vs. Dividends (by Armand – new contributing member)

Discover how the high dividend stock investment strategy compares to the buy and hold approach, two investment philosophies with similar goals but different rewards. An in-depth analysis that highlights the tax advantages and growth prospects of these strategies, illustrated in particular by the emblematic example of Microsoft.

Buy & Hold vs. Dividends (by Armand – new contributing member) Read More »

BiC (Paris:BB)

BIC, famous for its pens, razors and lighters, stands out for its cost management strategy and its majority in-house production. The French company, which has also launched into mobile phones with the BIC Phone, has a good return-to-risk ratio and could represent an interesting investment opportunity despite some volatility.

BiC (Paris:BB) Read More »

Swisscom (VTX:SCMN)

Find out why Swisscom, the leading Swiss telecommunications company with over 50% mobile market share, represents an attractive investment opportunity. With a solid and growing dividend, low sensitivity to currency risks and a dominant position in its home market, Swisscom is a strategic choice for investors seeking stability and returns.

Swisscom (VTX:SCMN) Read More »

Abbott Laboratories (NYSE:ABT)

Abbott Laboratories, an American pharmaceutical company founded in Chicago, split in 2013 into two separate entities: Abbott (ABT) specializing in nutrition and medical devices, and AbbVie (ABBV) focused on drugs. This historic company, characterized by its stability and regular dividend growth, continues to demonstrate its strength in the market with controlled volatility and an effective concentration strategy.

Abbott Laboratories (NYSE:ABT) Read More »

Biomerieux (Paris:BIM)

bioMérieux, a world leader in microbiology and in vitro diagnostics, offers innovative solutions for the detection of infectious diseases and food safety. The French company, with a century of family expertise, is expanding internationally while maintaining a growth-oriented strategy in emerging fields such as molecular biology, offering a stable stock profile despite a moderate return.

Biomerieux (Paris:BIM) Read More »